{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:02:34Z","timestamp":1789635754180,"version":"4.0.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-026-02063-7","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:28:09Z","timestamp":1775888889000},"page":"3449-3468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Experimental Validation and Computational Deconstruction of Downstream Mutations in MIR5195: Integrating Whole-Exome Sequencing, Structural Dynamics, and Molecular Docking to Decipher Transcriptional Reprogramming in CML"],"prefix":"10.1007","volume":"84","author":[{"given":"Sameen","family":"Shahid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0135-2991","authenticated-orcid":false,"given":"Muhammad Farooq","family":"Sabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafar","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"2","key":"2063_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5306\/wjco.v12.i2.69","volume":"12","author":"MM Sampaio","year":"2021","unstructured":"Sampaio, M. M., et al. (2021). Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review. World journal of clinical oncology, 12(2), 69.","journal-title":"World journal of clinical oncology"},{"key":"2063_CR2","doi-asserted-by":"publisher","first-page":"742802","DOI":"10.3389\/fgene.2021.742802","volume":"12","author":"M Amir","year":"2021","unstructured":"Amir, M., & Javed, S. (2021). A review on the therapeutic role of TKIs in case of CML in combination with epigenetic drugs. Frontiers in genetics, 12, 742802.","journal-title":"Frontiers in genetics"},{"issue":"6","key":"2063_CR3","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/CMR.0000000000000926","volume":"33","author":"M Rubatto","year":"2023","unstructured":"Rubatto, M., et al. (2023). Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies. Melanoma Research, 33(6), 462\u2013474.","journal-title":"Melanoma Research"},{"issue":"1","key":"2063_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/cbf.3079","volume":"33","author":"B Santosh","year":"2015","unstructured":"Santosh, B., Varshney, A., & Yadava, P. K. (2015). Non-coding RNAs: biological functions and applications. Cell biochemistry and function, 33(1), 14\u201322.","journal-title":"Cell biochemistry and function"},{"issue":"20","key":"2063_CR5","first-page":"3143","volume":"7","author":"MJ Bueno","year":"2008","unstructured":"Bueno, M. J., de Castro, I. P., & Malumbres, M. (2008). Control of cell proliferation pathways by microRNAs Cell cycle, 7(20): 3143\u20133148.","journal-title":"Control of cell proliferation pathways by microRNAs Cell cycle"},{"issue":"1","key":"2063_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1476-4598-10-41","volume":"10","author":"K Machov\u00e1 Pol\u00e1kov\u00e1","year":"2011","unstructured":"Machov\u00e1 Pol\u00e1kov\u00e1, K., et al. (2011). Expression patterns of microRNAs associated with CML phases and their disease related targets. Molecular cancer, 10(1), 41.","journal-title":"Molecular cancer"},{"key":"2063_CR7","doi-asserted-by":"crossref","unstructured":"Yu, W. (2018). MicroRNA-195: a review of its role in cancers. Oncotargets and therapy, : pp. 7109\u20137123.","DOI":"10.2147\/OTT.S183600"},{"issue":"12","key":"2063_CR8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41577-023-00893-7","volume":"23","author":"JL Trujillo-Ochoa","year":"2023","unstructured":"Trujillo-Ochoa, J. L., Kazemian, M., & Afzali, B. (2023). The role of transcription factors in shaping regulatory T cell identity. Nature Reviews Immunology, 23(12), 842\u2013856.","journal-title":"Nature Reviews Immunology"},{"issue":"suppl_2","key":"2063_CR9","doi-asserted-by":"publisher","first-page":"W369","DOI":"10.1093\/nar\/gkl198","volume":"34","author":"TL Bailey","year":"2006","unstructured":"Bailey, T. L., et al. (2006). MEME: discovering and analyzing DNA and protein sequence motifs. Nucleic acids research, 34(suppl_2), W369\u2013W373.","journal-title":"Nucleic acids research"},{"issue":"1","key":"2063_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev.biophys.27.1.105","volume":"27","author":"CA Bewley","year":"1998","unstructured":"Bewley, C. A., Gronenborn, A. M., & Clore, G. M. (1998). Minor groove-binding architectural proteins: structure, function, and DNA recognition. Annual review of biophysics and biomolecular structure, 27(1), 105\u2013131.","journal-title":"Annual review of biophysics and biomolecular structure"},{"issue":"2","key":"2063_CR11","first-page":"489","volume":"90","author":"DG Tenen","year":"1997","unstructured":"Tenen, D. G., et al. (1997). Transcription factors, normal myeloid development, and leukemia. The Journal of the American Society of Hematology, 90(2), 489\u2013519. Blood.","journal-title":"The Journal of the American Society of Hematology"},{"issue":"5","key":"2063_CR12","first-page":"1495","volume":"25","author":"M Katoh","year":"2004","unstructured":"Katoh, M., & Katoh, M. (2004). Human FOX gene family. International journal of oncology, 25(5), 1495\u20131500.","journal-title":"International journal of oncology"},{"key":"2063_CR13","unstructured":"Choudhury, S. (2024). Journal of Archives in Oncology Research."},{"key":"2063_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bcp.2017.06.122","volume":"144","author":"M Hecker","year":"2017","unstructured":"Hecker, M., & Wagner, A. H. (2017). Transcription factor decoy technology: A therapeutic update. Biochemical Pharmacology, 144, 29\u201334.","journal-title":"Biochemical Pharmacology"},{"issue":"3","key":"2063_CR15","first-page":"386","volume":"1","author":"YS Cho-Chung","year":"1999","unstructured":"Cho-Chung, Y. S., Park, Y. G., & Lee, Y. N. (1999). Oligonucleotides as transcription factor decoys. Current Opinion In Molecular Therapeutics, 1(3), 386\u2013392.","journal-title":"Current Opinion In Molecular Therapeutics"},{"issue":"10","key":"2063_CR16","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/01.RES.82.10.1023","volume":"82","author":"R Morishita","year":"1998","unstructured":"Morishita, R., et al. (1998). Application of transcription factor decoy strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circ Res, 82(10), 1023\u20131028.","journal-title":"Circ Res"},{"key":"2063_CR17","doi-asserted-by":"crossref","unstructured":"Baccarani, M. (2013). European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. 122(6): 872\u2013884.","DOI":"10.1182\/blood-2013-05-501569"},{"key":"2063_CR18","doi-asserted-by":"crossref","unstructured":"Cortes, J. E. (2006). Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal. 106(6): 1306\u20131315.","DOI":"10.1002\/cncr.21756"},{"key":"2063_CR19","doi-asserted-by":"crossref","unstructured":"Suttorp, M., et al., Definition, Epidemiology, Pathophysiology, and Essential Criteria for Diagnosis of Pediatric Chronic Myeloid Leukemia. Cancers (Basel), 2021. 13(4). https:\/\/pubmed.ncbi.nlm.nih.gov\/33672937\/","DOI":"10.3390\/cancers13040798"},{"issue":"2","key":"2063_CR20","first-page":"310","volume":"20","author":"FX Mahon","year":"2014","unstructured":"Mahon, F. X., & Etienne, G. J. C. C. R. (2014). Deep molecular response in chronic myeloid leukemia: the new goal of therapy? 20(2): 310\u2013322.","journal-title":"Deep molecular response in chronic myeloid leukemia: the new goal of therapy?"},{"key":"2063_CR21","doi-asserted-by":"crossref","unstructured":"Cross, N. (2012). Standardized definitions of molecular response in chronic myeloid leukemia. 26(10): 2172\u20132175.","DOI":"10.1038\/leu.2012.104"},{"issue":"1","key":"2063_CR22","first-page":"44","volume":"14","author":"J Cortes","year":"2021","unstructured":"Cortes, J., Lang, F. J. J. H., & Oncology (2021). Third-line therapy for chronic myeloid leukemia: current status and future directions 14(1): 44.","journal-title":"Third-line therapy for chronic myeloid leukemia: current status and future directions"},{"issue":"3","key":"2063_CR23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.scijus.2015.01.005","volume":"55","author":"SC Ip","year":"2015","unstructured":"Ip,S. C., Lin, S. W., & Lai, K. M. (2015). An evaluation of the performance of five extraction methods: Chelex\u00ae 100, QIAamp\u00ae DNA Blood Mini Kit, QIAamp\u00ae DNA Investigator Kit, QIAsymphony\u00ae DNA Investigator\u00ae Kit and DNA IQ\u2122. Science & Justice, 55(3), 200\u2013208. https:\/\/doi.org\/10.1016\/j.scijus.2015.01.005","journal-title":"Science & Justice"},{"issue":"3(Special)","key":"2063_CR24","first-page":"1419","volume":"33","author":"M Absar","year":"2020","unstructured":"Absar,M., et al. (2020). Whole exome sequencing identifies a novel FANCD2 gene splice site mutation associated with disease progression in chronic myeloid leukemia: Implication in targeted therapy of advanced phase CML. Pakistan Journal Of Pharmaceutical Sciences, 33(3(Special)), 1419\u20131426. https:\/\/pubmed.ncbi.nlm.nih.gov\/33361032\/","journal-title":"Pakistan Journal Of Pharmaceutical Sciences"},{"issue":"7","key":"2063_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/gim.2015.148","volume":"18","author":"K Retterer","year":"2016","unstructured":"Retterer,K., et al. (2016). Clinical application of whole-exome sequencing across clinical indications. Genet Med, 18(7), 696\u2013704. https:\/\/pubmed.ncbi.nlm.nih.gov\/26633542\/","journal-title":"Genet Med"},{"issue":"1","key":"2063_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1172\/JCI78473","volume":"125","author":"S AlAsiri","year":"2015","unstructured":"AlAsiri,S., et al. (2015). Exome sequencing reveals MCM8 mutation underlies ovarian failure and chromosomal instability. J Clin Invest, 125(1), 258\u2013262. https:\/\/pubmed.ncbi.nlm.nih.gov\/25437880\/","journal-title":"J Clin Invest"},{"issue":"4","key":"2063_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2353\/jmoldx.2010.090188","volume":"12","author":"AC Tsiatis","year":"2010","unstructured":"Tsiatis,A. C., et al. (2010). Comparison of Sanger Sequencing, Pyrosequencing, and Melting Curve Analysis for the Detection of KRAS Mutations: Diagnostic and Clinical Implications. The Journal of Molecular Diagnostics, 12(4), 425\u2013432. https:\/\/doi.org\/10.2353\/jmoldx.2010.090188","journal-title":"The Journal of Molecular Diagnostics"},{"issue":"W1","key":"2063_CR28","doi-asserted-by":"publisher","first-page":"W39","DOI":"10.1093\/nar\/gkv416","volume":"43","author":"TL Bailey","year":"2015","unstructured":"Bailey, T. L., et al. (2015). The MEME suite. Nucleic acids research, 43(W1), W39\u2013W49.","journal-title":"Nucleic acids research"},{"issue":"2","key":"2063_CR29","doi-asserted-by":"publisher","first-page":"R24","DOI":"10.1186\/gb-2007-8-2-r24","volume":"8","author":"S Gupta","year":"2007","unstructured":"Gupta, S., et al. (2007). Quantifying similarity between motifs. Genome biology, 8(2), R24.","journal-title":"Genome biology"},{"issue":"5","key":"2063_CR30","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41588-023-01365-3","volume":"55","author":"S Dong","year":"2023","unstructured":"Dong, S., et al. (2023). Annotating and prioritizing human non-coding variants with RegulomeDB v. 2. Nature genetics, 55(5), 724\u2013726.","journal-title":"Nature genetics"},{"issue":"8016","key":"2063_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J., et al. (2024). Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature, 630(8016), 493\u2013500.","journal-title":"Nature"},{"issue":"12","key":"2063_CR32","doi-asserted-by":"publisher","first-page":"e0166944","DOI":"10.1371\/journal.pone.0166944","volume":"11","author":"SM Corley","year":"2016","unstructured":"Corley, S. M., et al. (2016). Transcriptomic analysis shows decreased cortical expression of NR4A1, NR4A2 and RXRB in schizophrenia and provides evidence for nuclear receptor dysregulation. PloS one, 11(12), e0166944.","journal-title":"PloS one"},{"issue":"3","key":"2063_CR33","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1158\/1078-0432.1065.11.3","volume":"11","author":"AH Banham","year":"2005","unstructured":"Banham, A. H., et al. (2005). Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Clinical cancer research, 11(3), 1065\u20131072.","journal-title":"Clinical cancer research"},{"issue":"6711","key":"2063_CR34","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/25166","volume":"396","author":"J Boyes","year":"1998","unstructured":"Boyes, J., et al. (1998). Regulation of activity of the transcription factor GATA-1 by acetylation. Nature, 396(6711), 594\u2013598.","journal-title":"Nature"},{"issue":"2","key":"2063_CR35","first-page":"488","volume":"93","author":"DA Persons","year":"1999","unstructured":"Persons, D. A., et al. (1999). Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood. The Journal of the American Society of Hematology, 93(2), 488\u2013499.","journal-title":"The Journal of the American Society of Hematology"},{"issue":"5","key":"2063_CR36","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Y Yan","year":"2020","unstructured":"Yan, Y., et al. (2020). The HDOCK server for integrated protein\u2013protein docking. Nature protocols, 15(5), 1829\u20131852.","journal-title":"Nature protocols"},{"issue":"2","key":"2063_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0167-4781(01)00264-0","volume":"1520","author":"C Hallenberg","year":"2001","unstructured":"Hallenberg, C., & Frederiksen, S. (2001). Effect of mutations in the upstream promoter on the transcription of human 5S rRNA genes. Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression, 1520(2), 169\u2013173.","journal-title":"Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression"},{"issue":"11","key":"2063_CR38","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrm3884","volume":"15","author":"WH Hudson","year":"2014","unstructured":"Hudson, W. H., & Ortlund, E. A. (2014). The structure, function and evolution of proteins that bind DNA and RNA. Nature reviews Molecular cell biology, 15(11), 749\u2013760.","journal-title":"Nature reviews Molecular cell biology"},{"issue":"43","key":"2063_CR39","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1038\/onc.2009.243","volume":"28","author":"M B\u00f6hm","year":"2009","unstructured":"B\u00f6hm, M., et al. (2009). A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes. Oncogene, 28(43), 3847\u20133856.","journal-title":"Oncogene"},{"issue":"11","key":"2063_CR40","doi-asserted-by":"publisher","first-page":"9852","DOI":"10.18632\/oncotarget.23955","volume":"9","author":"T Chano","year":"2018","unstructured":"Chano, T., et al. (2018). Prominent role of RAB39A-RXRB axis in cancer development and stemness. Oncotarget, 9(11), 9852.","journal-title":"Oncotarget"},{"issue":"10","key":"2063_CR41","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.3390\/genes13101754","volume":"13","author":"H Yin","year":"2022","unstructured":"Yin, H., et al. (2022). An integrated study on the differential expression of the FOX gene family in cancer and their response to chemotherapy drugs. Genes, 13(10), 1754.","journal-title":"Genes"},{"key":"2063_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bcp.2017.06.122","volume":"144","author":"M Hecker","year":"2017","unstructured":"Hecker, M., & Wagner, A. H. (2017). Transcription factor decoy technology: A therapeutic update. Biochemical Pharmacology, 144, 29\u201334.","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"2063_CR43","doi-asserted-by":"publisher","first-page":"15316","DOI":"10.1038\/s41598-020-72136-x","volume":"10","author":"S Imbaby","year":"2020","unstructured":"Imbaby, S., et al. (2020). Beneficial effect of STAT3 decoy oligodeoxynucleotide transfection on organ injury and mortality in mice with cecal ligation and puncture-induced sepsis. Scientific Reports, 10(1), 15316.","journal-title":"Scientific Reports"},{"issue":"6","key":"2063_CR44","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/labinvest.2008.38","volume":"88","author":"I Moriyama","year":"2008","unstructured":"Moriyama, I., et al. (2008). Decoy oligodeoxynucleotide targeting activator protein-1 (AP-1) attenuates intestinal inflammation in murine experimental colitis. Laboratory Investigation, 88(6), 652\u2013663.","journal-title":"Laboratory Investigation"},{"issue":"30","key":"2063_CR45","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1038\/sj.onc.1210229","volume":"26","author":"K Takayama","year":"2007","unstructured":"Takayama, K., et al. (2007). Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis. Oncogene, 26(30), 4453\u20134463.","journal-title":"Oncogene"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02063-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-026-02063-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02063-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:16:36Z","timestamp":1789632996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-026-02063-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2063"],"URL":"https:\/\/doi.org\/10.1007\/s12013-026-02063-7","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"24 March 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}